Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Baird analyst Andrew Wittmann initiates coverage on Acuren (NYSE:TIC) with a Neutral rating and announces Price Target of $15.
UBS analyst Joshua Chan maintains Acuren (NYSE:TIC) with a Neutral and raises the price target from $11 to $15.
Acuren (NYSE:TIC) sees FY2025 sales of $1.530 billion-$1.565 billion vs $1.139 billion analyst estimate.
Acuren (NYSE:TIC) sees Q3 sales of $460.000 million-$480.000 million vs $483.005 million analyst estimate.
